Cort
Phoenix Rising Founder
- Messages
- 7,392
Interesting article on a very different way to treat muscle and joint pain; one that may perhaps be attuned to the problems in ME/CFS and FM (?)
Treating Musculoskeletal Pain Conditions with Prolotherapy By Jeffery J. Ericksen, MD http://www.pain.com/sections/professional/articles/article.cfm?id=94
This reminds me of Mike's doctor. He uses prolotherapy but his main focus is homeopathic injections using Neural therapy; the interesting thing to me is that he's using injections of solutions to provoke a healing response in both instances.
There's alot of pain in fibromyalgia and CFS - none of which is usually associated with swelling or redness (inflammation) making it a mystery. But prolotherapy is not treating inflammation - its treating "degenerative connective tissue problems" with 'collagen thinning and fraying'.
In fact prolotherapy appears to trigger a local inflammatory response - which then, hopefully, builds collagen.
They actually inject 'irritants' into these damaged tissues!
They also use "Osmotic shock agents" to provoke a healing response.
Interesting therapy!
Article Created: January, 27, 2009
Treating Musculoskeletal Pain Conditions with Prolotherapy By Jeffery J. Ericksen, MD http://www.pain.com/sections/professional/articles/article.cfm?id=94
Prolotherapy (PrT) is an injection treatment for musculoskeletal pain syndromes that stem from connective tissue injuries or damage from chronic degenerative conditions and overuse syndromes.
PrT derives its name from proliferant therapy and was formerly known as sclerotherapy although research has demonstrated that PrT, done using solutions that induce a localized inflammatory or healing response, are stimulating organized connective tissue regeneration and not scar formation. Most practitioners stopped using the term sclerotherapy in the 1950s. The term “ligament and tendon regenerative injection therapy” has been suggested, but is not yet widely accepted in clinical use.
PrT was championed in the 1950s by Dr. George Hackett who extensively used this treatment in his general surgical practice that focused on treating chronic pain conditions. He injected small volumes of proliferant solutions into painful tendon and ligament insertion sites known as entheses (fibro-osseus junctions) serially, typically for 3-6 treatment sessions over monthly intervals. Dr. Hackett’s book remains the premier discussion of PrT for chronic pain management with proliferant injections [1].
This reminds me of Mike's doctor. He uses prolotherapy but his main focus is homeopathic injections using Neural therapy; the interesting thing to me is that he's using injections of solutions to provoke a healing response in both instances.
There's alot of pain in fibromyalgia and CFS - none of which is usually associated with swelling or redness (inflammation) making it a mystery. But prolotherapy is not treating inflammation - its treating "degenerative connective tissue problems" with 'collagen thinning and fraying'.
The use of PrT for musculoskeletal conditions is based on the growing understanding that most conditions are not due to active inflammation. Histological study, MRI, and ultrasound imaging methods have demonstrated that these tissues manifest few if any inflammatory cells. Instead, degenerative connective tissue fibrils with collagen thinning, fraying, and disruption with immature non-functional blood vessels (neovascularization) has been noted in tendon structures. Thus, the focus of treatment has shifted away from inhibiting inflammation and toward the direction of stimulating tissue recovery or regeneration.
In fact prolotherapy appears to trigger a local inflammatory response - which then, hopefully, builds collagen.
The theory behind PrT is that injections cause local tissue injury, which triggers the release of inflammatory mediators. Ongoing debate centers on the role of the specific solution vs. the role of the tissue injury caused by the needle penetrating tissues that advocates of dry needling argue as the necessary event. Inflammatory mediators then stimulate granulocytes and macrophages to begin activity from growth factors released. Fibroblasts are then stimulated that synthesizes collagen at the injury site followed by maturation of the collagen fibrils to tighten and strengthen the tissue. Recruitment of circulating stem cells is possible from the growth factor release seen in PrT treatment.
They actually inject 'irritants' into these damaged tissues!
Traditional PrT solutions are classified based on their effect on local tissues. Irritant solutions include:
- Phenol
- Particulate solutions (such as ground pumice flour)
- Phenol-quinone urea
These solutions damage cells by oxidizing and alkylating surface proteins which potentially renders cells as antigenic and immediately stimulates the inflammatory cascade and recruits macrophages that secrete growth factors.
They also use "Osmotic shock agents" to provoke a healing response.
Osmotic shock agents create cells via osmotic pressure gradients, glycosylation of surface proteins, and metallation of proteins. This leads to granulocyte and macrophage attraction. Chemotactic agents, such as sodium morrhuate (cod liver oil salt), directly attract inflammatory cells plus fibroblasts. Sodium morrhuate is rich in arachidonic acid acting as a precursor for prostaglandins, leukotrienes, and thromboxanes necessary for inflammation.
- Dextrose
- Glycerin
- Zinc sulfate
Interesting therapy!
Article Created: January, 27, 2009